{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T05:04:18Z","timestamp":1789535058712,"version":"build-2803163510"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Cytotoxic T-lymphocyte-associated protein 4 (CTLA4) haploinsufficiency with autoimmune infiltration (CHAI) is an autosomal dominant condition featuring both immunodeficiency and autoimmunity. We describe the first published mainland Chinese patient harboring the heterozygous CTLA4 c.529dupT frameshift variant. While multiple CHAI cases have been documented in mainland China, this specific variant has not been reported in this population to date. The patient developed recurrent thrombocytopenia, recurrent respiratory infections and hypogammaglobulinemia at age 2. She was diagnosed with immune thrombocytopenia (ITP) at age 15. The disease subsequently progressed to Evans syndrome, alongside complications including chronic diarrhea, cerebral vasculitis, biliary tract infection and interstitial pneumonia. She received standard anti-infective therapy, combined glucocorticoids and immunosuppressants, as well as intravenous immunoglobulin (IVIG) replacement; however, these interventions yielded only limited and temporary benefits. After 38 years of disease progression, a primary immunodeficiency was suspected. Whole-exome sequencing (WES) verified the diagnosis of CHAI. Treatment with sirolimus led to amelioration of infection and diarrheal symptoms. This case exhibited phenotypic differences from prior patients carrying the identical variant. Our observations expand the known phenotypic spectrum of this variant and offer clinical references for the management and genetic testing of patients presenting with early-onset multisystem autoimmunity and immunodeficiency.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1899668","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T04:30:15Z","timestamp":1789533015000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: The first Mainland Chinese case of CTLA4 c.529dupT haploinsufficiency with a 38-year diagnostic delay"],"prefix":"10.3389","volume":"17","author":[{"given":"Xiang","family":"Gu","sequence":"first","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Shanghai Fourth People\u2019s Hospital, Tongji University School of Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Shanghai Fourth People\u2019s Hospital, Tongji University School of Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Shanghai Fourth People\u2019s Hospital, Tongji University School of Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Radiology, Second Affiliated Hospital of Naval Medical University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Lv","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Shanghai Fourth People\u2019s Hospital, Tongji University School of Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Shanghai Fourth People\u2019s Hospital, Tongji University School of Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1255904","article-title":"Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4","volume":"345","author":"Kuehn","year":"2014","journal-title":"Science"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/1074-7613(94)90071-X","article-title":"CTLA-4 can function as a negative regulator of T cell activation","volume":"1","author":"Walunas","year":"1994","journal-title":"Immunity"},{"key":"B3","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/imr.12721","article-title":"What did we learn from CTLA \u20104 insufficiency on the human immune system","volume":"287","author":"Mitsuiki","year":"2019","journal-title":"Immunol Rev"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3746","article-title":"Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations","volume":"20","author":"Schubert","year":"2014","journal-title":"Nat Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.02.055","article-title":"Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4\u2013insufficient subjects","volume":"142","author":"Schwab","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-04-712612","article-title":"CHAI and LATAIE: new genetic diseases of CTLA-4 checkpoint insufficiency","volume":"128","author":"Lo","year":"2016","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1011646","article-title":"Do common infections trigger disease-onset or -severity in CTLA-4 insufficiency","volume":"13","author":"Krausz","year":"2022","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/cei.13600","article-title":"Comprehensive comparison between 222 CTLA-4 haploinsufficiency and 212 LRBA deficiency patients: a systematic review","volume":"205","author":"Jamee","year":"2021","journal-title":"Clin Exp Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s41927-026-00637-9","article-title":"Clinical and genetic features of CTLA-4 haploinsufficiency: a prospective study in China","volume":"10","author":"Liu","year":"2026","journal-title":"BMC Rheumatol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cmcr.2022.e00625","article-title":"A case with recurrent neurological symptoms caused by a novel variation in CTLA-4 gene and literature review [Article in Chinese","volume":"4","author":"Yu","year":"2022","journal-title":"Chin Med Case Repository"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1000-484X.2019.02.018","article-title":"Mutation of CTLA4 causes primary immunodeficiency disease: one case report [Article in Chinese","volume":"35","author":"Zhang","year":"2019","journal-title":"Chin J Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn311367-20211207-00666","article-title":"Primary immunodeficiency disease caused by cytotoxic T lymphocyte-associated antigen-4 gene mutation [Article in Chinese","volume":"42","author":"Ai","year":"2022","journal-title":"Chin J Dig"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1665184","article-title":"A novel CTLA-4 deletion variant in a child with refractory autoimmune hemolytic anemia: molecular and functional characterization","volume":"16","author":"Chen","year":"2025","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn311367-20230701-00294","article-title":"Enteritis associated with cytotoxic T lymphocyte-associated antigen 4 haploinsufficiency: a case report [Article in Chinese","volume":"44","author":"An","year":"2024","journal-title":"Chin J Dig"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cmcr.2022.e03311","article-title":"A case of CTLA-4 haploinsufficiency with autoimmune infiltration [Article in Chinese","author":"Zhao","year":"2022","journal-title":"Chin Med Case Rep Database"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2021.04.039","article-title":"Therapeutic options for CTLA-4 insufficiency","volume":"149","author":"Egg","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2020.03.001","article-title":"Abatacept is effective in Chinese patients with LRBA and CTLA4 deficiency","volume":"8","author":"Yang","year":"2021","journal-title":"Genes Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13223-026-01011-7","article-title":"CTLA-4 haploinsufficiency presenting with chronic myeloid leukemia, bullous pemphigoid, and PLA2R-positive membranous nephropathy: a case report","volume":"22","author":"Deeb","year":"2026","journal-title":"Allergy Asthma Clin Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s10875-025-01934-7","article-title":"Beyond the classical triad: atypical presentations and regulatory T cell phenotyping in a cohort of IPEX patients","volume":"45","author":"Yaz","year":"2025","journal-title":"J ClinImmunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/pai.14179","article-title":"Analysis of LRBA pathogenic variants and the association with functional protein domains and clinical presentation","volume":"35","author":"Perez\u2010Perez","year":"2024","journal-title":"Pediatr Allergy Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2021.1945443","article-title":"Phosphatidylinositol 3-kinase signaling and immune regulation: insights into disease pathogenesis and clinical implications","volume":"17","author":"Nguyen","year":"2021","journal-title":"Expert Rev Clin Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.jaip.2025.04.014","article-title":"Dominant-negative versus gain-of-function STAT3 defects: A systematic review on epidemiological, clinical, immunological, and molecular aspects","volume":"13","author":"Hajialigol","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2023.07.001","article-title":"Understanding the spectrum of immune dysregulation manifestations in autoimmune lymphoproliferative syndrome and autoimmune lymphoproliferative syndrome-like disorders","volume":"49","author":"Failing","year":"2023","journal-title":"Rheum Dis Clin N Am"},{"key":"B24","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/10408363.2024.2404842","article-title":"The role of immunophenotyping in common variable immunodeficiency: a narrative review","volume":"62","author":"Neirinck","year":"2025","journal-title":"Crit Rev Clin Lab Sci"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1899668\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T04:30:44Z","timestamp":1789533044000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1899668\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":24,"alternative-id":["10.3389\/fimmu.2026.1899668"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1899668","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"article-number":"1899668"}}